Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by skyhigh123on Mar 20, 2018 7:52pm
225 Views
Post# 27750140

RE:RE:RE:Announcement of the BLA for PLI's Plasminogen Next Monday?

RE:RE:RE:Announcement of the BLA for PLI's Plasminogen Next Monday?For thottseewho are not up to date with FDA procedures.
They only have a Pediatric meeting if there. Is a Pediatric approval for that month. 
And so forth for all the other indications..

example reead  explo2025 last post 

sky 

drybones if you really read this board you would have Known this instead of arguing omg your?


Bullboard Posts